Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
Neuropharmacology. 2010 Feb;58(2):495-500. doi: 10.1016/j.neuropharm.2009.09.001. Epub 2009 Sep 8.
Nefopam, a non-opioid, centrally acting benzoxazocine analgesic, proved to be as efficient in treatment of postanaesthetic thermoregulatory shivering as clonidine or meperidine. However, its exact mechanism of action is still unclear. Potent anti-shivering activity was also demonstrated for physostigmine primarily based on cholinergic but probably also different additional mechanisms of action. Hypothesizing an involvement of alpha(2)-adrenoceptors we studied their role in nefopam- and physostigmine-mediated thermoregulation in a mouse model of nonshivering thermogenesis. To differentiate possible alpha(2)-adrenoceptor subtype-specific interactions, we analysed wildtype mice and mice with deletion of the alpha(2A)-, alpha(2B)- or alpha(2C)-adrenoceptor (knock out). Ten mice of each genotype (n = 40) were administered saline, saline plus atipamezole, 1 mg/kg nefopam, 25 mg/kg nefopam, 25 mg/kg nefopam plus atipamezole, physostigmine and physostigmine plus atipamezole intraperitoneally. Each mouse was randomly subjected to each of the seven different treatments. Afterwards, the mice were positioned into a plexiglas chamber where rectal temperature and mixed expired carbon dioxide were measured during following whole body cooling. Thermoregulatory threshold temperature of nonshivering thermogenesis and maximum response intensity were analysed. Nefopam decreased the thermoregulatory threshold temperature in wildtype, alpha(2B)- and alpha(2C)-adrenoceptor mice. This effect was partially abolished by additional administration of the alpha(2)-adrenoceptor antagonist atipamezole. In alpha(2A)-adrenoceptor knock out mice, nefopam did not affect the thermoregulatory threshold. In contrast, physostigmine decreased the thermoregulatory threshold in wildtype and all alpha(2)-adrenoceptor knock out mice independently from additional atipamezole administration. Our results indicate an important role of the alpha(2A)-adrenoceptor in the thermoregulatory response induced by nefopam but not by physostigmine in mice.
奈福泮是一种非阿片类、中枢作用的苯并恶嗪类镇痛药,在治疗麻醉后体温调节性颤抖方面与可乐定或哌替啶同样有效。然而,其确切的作用机制仍不清楚。基于胆碱能作用,毒扁豆碱也表现出很强的抗寒战活性,但可能还有其他不同的作用机制。我们假设涉及α2-肾上腺素能受体,并在非寒战产热的小鼠模型中研究了它们在奈福泮和毒扁豆碱介导的体温调节中的作用。为了区分可能的α2-肾上腺素能受体亚型特异性相互作用,我们分析了野生型小鼠和α2A-、α2B-或α2C-肾上腺素能受体缺失(敲除)的小鼠。每种基因型(n=40)各有 10 只小鼠接受生理盐水、生理盐水加阿替美唑、1mg/kg 奈福泮、25mg/kg 奈福泮、25mg/kg 奈福泮加阿替美唑、毒扁豆碱和毒扁豆碱加阿替美唑腹膜内注射。每只小鼠随机接受七种不同处理中的一种。之后,将小鼠放入有机玻璃室中,在全身冷却过程中测量直肠温度和混合呼出的二氧化碳。分析非寒战产热的体温调节阈值温度和最大反应强度。奈福泮降低了野生型、α2B-和α2C-肾上腺素能受体小鼠的体温调节阈值。这种作用部分被α2-肾上腺素能受体拮抗剂阿替美唑的额外给药所消除。在α2A-肾上腺素能受体敲除小鼠中,奈福泮不影响体温调节阈值。相反,毒扁豆碱降低了野生型和所有α2-肾上腺素能受体敲除小鼠的体温调节阈值,而与是否额外给予阿替美唑无关。我们的结果表明,α2A-肾上腺素能受体在奈福泮诱导的体温调节反应中起重要作用,但在小鼠中,毒扁豆碱不依赖于α2-肾上腺素能受体。